In the meantime, patients are left to navigate a complex and rapidly shifting landscape on their own
As GLP-1 receptor agonists such as semaglutide, liraglutide, and exenatide become more widely used in treating diabetes and obesity, the demand for accurate analytical characterization continues to grow
However, due to GLP-1s short-term metabolic effects, agonists are utilized as they mimic the effects of GLP-1 long-term, such as binding the receptors that GLP-1 normally binds to, and have shown promising results in treating type 1 diabetes mellitus as well ( Mohandas et al
Therefore, various antidiabetic agents are under research and development
Abstract Heart Failure with Preserved Ejection Fraction (HFpEF) represents a significant challenge in modern cardiovascular medicine, characterized by diastolic dysfunction and a chronic pro-inflammatory milieu